392 related articles for article (PubMed ID: 17327887)
21. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia.
Molina V; Reig S; Sanz J; Palomo T; Benito C; Sánchez J; Sarramea F; Pascau J; Desco M
Schizophr Res; 2005 Dec; 80(1):61-71. PubMed ID: 16150576
[TBL] [Abstract][Full Text] [Related]
22. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity.
Hulshoff Pol HE; Schnack HG; Mandl RC; Cahn W; Collins DL; Evans AC; Kahn RS
Neuroimage; 2004 Jan; 21(1):27-35. PubMed ID: 14741639
[TBL] [Abstract][Full Text] [Related]
23. Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study.
Tamagaki C; Sedvall GC; Jönsson EG; Okugawa G; Hall H; Pauli S; Agartz I
Am J Psychiatry; 2005 Dec; 162(12):2315-21. PubMed ID: 16330596
[TBL] [Abstract][Full Text] [Related]
24. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia.
Vidal CN; Rapoport JL; Hayashi KM; Geaga JA; Sui Y; McLemore LE; Alaghband Y; Giedd JN; Gochman P; Blumenthal J; Gogtay N; Nicolson R; Toga AW; Thompson PM
Arch Gen Psychiatry; 2006 Jan; 63(1):25-34. PubMed ID: 16389194
[TBL] [Abstract][Full Text] [Related]
25. Changes in cortical thickness during the course of illness in schizophrenia.
van Haren NE; Schnack HG; Cahn W; van den Heuvel MP; Lepage C; Collins L; Evans AC; Hulshoff Pol HE; Kahn RS
Arch Gen Psychiatry; 2011 Sep; 68(9):871-80. PubMed ID: 21893656
[TBL] [Abstract][Full Text] [Related]
26. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.
Cahn W; Hulshoff Pol HE; Lems EB; van Haren NE; Schnack HG; van der Linden JA; Schothorst PF; van Engeland H; Kahn RS
Arch Gen Psychiatry; 2002 Nov; 59(11):1002-10. PubMed ID: 12418933
[TBL] [Abstract][Full Text] [Related]
27. Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia.
Okugawa G; Nobuhara K; Takase K; Saito Y; Yoshimura M; Kinoshita T
Neuropsychobiology; 2007; 55(1):43-6. PubMed ID: 17556852
[TBL] [Abstract][Full Text] [Related]
28. Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia.
Nesvåg R; Frigessi A; Jönsson EG; Agartz I
Schizophr Res; 2007 Feb; 90(1-3):52-61. PubMed ID: 17218084
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.
Eack SM; Hogarty GE; Cho RY; Prasad KM; Greenwald DP; Hogarty SS; Keshavan MS
Arch Gen Psychiatry; 2010 Jul; 67(7):674-82. PubMed ID: 20439824
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder.
Farrow TF; Whitford TJ; Williams LM; Gomes L; Harris AW
Biol Psychiatry; 2005 Nov; 58(9):713-23. PubMed ID: 15993858
[TBL] [Abstract][Full Text] [Related]
31. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
Witthaus H; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Gallinat J; Ruhrmann S; Brüne M; Heinz A; Klingebiel R; Juckel G
Psychiatry Res; 2009 Sep; 173(3):163-9. PubMed ID: 19616415
[TBL] [Abstract][Full Text] [Related]
32. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies.
Olabi B; Ellison-Wright I; McIntosh AM; Wood SJ; Bullmore E; Lawrie SM
Biol Psychiatry; 2011 Jul; 70(1):88-96. PubMed ID: 21457946
[TBL] [Abstract][Full Text] [Related]
33. Decreased left middle temporal gyrus volume in antipsychotic drug-naive, first-episode schizophrenia patients and their healthy unaffected siblings.
Hu M; Li J; Eyler L; Guo X; Wei Q; Tang J; Liu F; He Z; Li L; Jin H; Liu Z; Wang J; Liu F; Chen H; Zhao J
Schizophr Res; 2013 Mar; 144(1-3):37-42. PubMed ID: 23360727
[TBL] [Abstract][Full Text] [Related]
34. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?
Borgwardt SJ; Smieskova R; Fusar-Poli P; Bendfeldt K; Riecher-Rössler A
Psychol Med; 2009 Nov; 39(11):1781-2. PubMed ID: 19476691
[No Abstract] [Full Text] [Related]
35. Phospholipase A2 activity is associated with structural brain changes in schizophrenia.
Smesny S; Milleit B; Nenadic I; Preul C; Kinder D; Lasch J; Willhardt I; Sauer H; Gaser C
Neuroimage; 2010 Oct; 52(4):1314-27. PubMed ID: 20478385
[TBL] [Abstract][Full Text] [Related]
36. Differential relationship of frontal pole and whole brain volumetric measures with age in neuroleptic-naïve schizophrenia and healthy subjects.
John JP; Burgess PW; Yashavantha BS; Shakeel MK; Halahalli HN; Jain S
Schizophr Res; 2009 Apr; 109(1-3):148-58. PubMed ID: 19185466
[TBL] [Abstract][Full Text] [Related]
37. Source-based morphometry of gray matter volume in patients with schizophrenia who have persistent auditory verbal hallucinations.
Kubera KM; Sambataro F; Vasic N; Wolf ND; Frasch K; Hirjak D; Thomann PA; Wolf RC
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():102-9. PubMed ID: 24321225
[TBL] [Abstract][Full Text] [Related]
38. Subarachnoid hemorrhage in the subacute stage: elevated apparent diffusion coefficient in normal-appearing brain tissue after treatment.
Liu Y; Soppi V; Mustonen T; Könönen M; Koivisto T; Koskela A; Rinne J; Vanninen RL
Radiology; 2007 Feb; 242(2):518-25. PubMed ID: 17179395
[TBL] [Abstract][Full Text] [Related]
39. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
[TBL] [Abstract][Full Text] [Related]
40. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report.
Takahashi T; Suzuki M; Tanino R; Zhou SY; Hagino H; Niu L; Kawasaki Y; Seto H; Kurachi M
Psychiatry Res; 2007 Apr; 154(3):209-19. PubMed ID: 17321114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
